Zobrazeno 1 - 10
of 24
pro vyhledávání: '"S-15535"'
Autor:
Paul M. Grasby, Philip J. Cowen, Ewen Sedman, Elizabeth Mocaer, Peter A. Sargent, Martin R. Wilkins, Eugenii A Rabiner, Roger N. Gunn
Serotonin 1A (5-HT 1A ) receptors have been implicated in the pathophysiology and treatment of anxiety and depression and are a target for novel drug development. In this qualitative study, positron emission tomography (PET) and [ carbonyl - 11 C]WAY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f31829a120b10eb2cac3229636fe2c7
https://ora.ox.ac.uk/objects/uuid:220fd3e0-fc1d-40bc-b8c0-263bc8d7d2e4
https://ora.ox.ac.uk/objects/uuid:220fd3e0-fc1d-40bc-b8c0-263bc8d7d2e4
Autor:
Patrick Genissel, Anne Dekeyne, Adrian Newman-Tancredi, Bertrand Goument, Marc Bertrand, Millan Mark, Valérie Charlot, Jean-Louis Peglion, Christian Nisole, Hélène Giraud, Nicole Despaux
Publikováno v:
Journal of Medicinal Chemistry. 45:165-176
S 15535 (1) displays a distinctive profile of agonist and antagonist (weak partial agonist) activity at pre- and postsynaptic 5-HT(1A) receptors, respectively. It has proven to be active in several models predictive of anxiolytic, antidepressant, and
Autor:
Roeline Jochemsen, Delphine Martin, Peter Vis, Meindert Danhof, Oscar Della Pasqua, Menno R. Kruk, Elisabeth Mocaer
Publikováno v:
European Journal of Pharmacology. 414:233-243
The pharmacokinetic-pharmacodynamic relationship of S 15535 (1-(benzodioxan-5-yl) 4-(indan-2-yl)piperazine) and its active 5-hydroxy metabolite S 32784 (1-(benzodioxan-5-yl) 4-(5-hydroxyindan-2-yl)piperazine), and buspirone as a reference, were studi
Publikováno v:
Neuropharmacology. 39:1037-1043
8-OH-DPAT [8-hydroxy-2-(di-N-propylamino)tetralin], a 5-HT(1A) receptor agonist, and S 15535 (4-benzodioxan-5-yl)1-(indan-2-yl)piperazine, a partial agonist at 5-HT(1A) receptors, were administered into the dorsal raphe nucleus and dorsal hippocampus
Publikováno v:
British Journal of Pharmacology. 128:1207-1214
The effect of S 15535 (4-benzodioxan-5-yl)1-(indan-2-yl)piperazine), an agonist at presynaptic and antagonist at postsynaptic 5-HT1A receptors, on the impairment of spatial learning caused by intrahippocampal scopolamine in a two-platform spatial dis
Autor:
Millan Mark, Françoise Lejeune
Publikováno v:
Synapse. 30:172-180
This study examined the influence of the highly selective 5-HT1A receptor ligands, flesinoxan, S 15535, and WAY 100,635, upon the electrical activity of dopaminergic neurons in the ventral tegmental area (VTA), as compared to serotonergic neurons in
Publikováno v:
Neuropharmacology. 36:451-459
Membrane preparations were made from Chinese Hamster Ovary (CHO) cells expressing 1.6 and 4.2 pmol/mg of recombinant human 5-HT 1A receptors, as determined by saturation binding with the selective antagonist, [ 3 H]-S 15535 ([ 3 H]-4-(benzodioxan-5-y
Autor:
Alain Gobert, M.J. Millan, J M Rivet, Valérie Audinot, Françoise Lejeune, Adrian Newman-Tancredi
Publikováno v:
European Neuropsychopharmacology. 6:S4-121
Autor:
Jean-Louis Peglion, Karin Bervoets, Millan Mark, Hervé Canton, Mauricette Brocco, Jean-Michel Rivet, Alain P. Gobert, Peter S. Widdowson, Françoise Lejeune
Publikováno v:
European Journal of Pharmacology. 230:99-102
The novel benzodioxopiperazine, S 15535 (4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine), displayed high affinity for 5-HT 1A binding sites (1.8 nM) whereas its affinity was 100-fold lower at other 5-HT 1A receptor types, at α 1 , α 2 - and β-adreno
Autor:
Valérie Audinot, Millan Mark, Alain Gobert, Mauricette Brocco, K Bervoets, S Le Marouille-Girardon, H Canton, Jean-Louis Peglion
Publikováno v:
ChemInform. 27
Benzocycloalkyl and benzocycloalkenyl moities linked, directly or via an alkyl chain, to oxygen-bearing heteroarylpiperazines were synthesized, in an attempt to obtain potent and selective antagonists at postsynaptic 5-HT 1A receptors. From the numer